Distal Protection Combined With PTCA in AMI Patients
NCT00264030 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2008-01-07
Summary
The primary objective is to evaluate if use of the AngioGuard™ XP improves myocardial reperfusion after PTCA as assessed by ST segment resolution at the end of PTCA.
Conditions
Interventions
- DEVICE
-
Angioguard distal protection device
PTCA with the Angioguard distal protection device.
- OTHER
-
PTCA
PTCA
Sponsors & Collaborators
-
Cordis Corporation
lead INDUSTRY
Principal Investigators
-
Thierry LEFEVRE, MD · Hopital Tarnier-Cochin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-03-31
- Completion
- 2004-08-31
Countries
- France
Study Locations
More Related Trials
-
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
NCT03090230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization
NCT04271033 ·Status: RECRUITING ·Phase: NA
-
Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT06103591 ·Status: COMPLETED ·Phase: NA
-
Advanced NanoTherapies Dual-API DCB to Treat De-Novo Lesions in Patients With Symptomatic Coronary Artery Disease
NCT05521542 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
NCT04201132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI
NCT02070731 ·Status: COMPLETED ·Phase: NA
-
The Angioshield Study Feasibility II
NCT02543047 ·Status: COMPLETED ·Phase: NA
-
PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI
NCT00534859 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
NCT00178672 ·Status: COMPLETED ·Phase: PHASE4
-
PREVENT: Promus BTK
NCT01500070 ·Status: COMPLETED ·Phase: PHASE2
-
CardioCel Tri-leaflet Repair Study
NCT02629328 ·Status: COMPLETED ·Phase: NA
-
SIMPLAAFY Clinical Trial
NCT06521463 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
NCT00600327 ·Status: COMPLETED ·Phase: PHASE3
-
AngelMed Guardian® System PMA Post Approval Study
NCT05412927 ·Status: RECRUITING
-
Clinical Study of Thoracic Excluder Endoprosthesis to Treat Descending Thoracic Aortic Diseases
NCT00546312 ·Status: UNKNOWN ·Phase: NA
-
MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction
NCT02292823 ·Status: TERMINATED
-
Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection
NCT03033043 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NCT02818972 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ENTRUST - TAArget® Thoracic Stent Graft Clinical Trial
NCT01033214 ·Status: UNKNOWN ·Phase: PHASE1
-
AMPLATZER Duct Occluder II Clinical Study
NCT00713700 ·Status: COMPLETED ·Phase: NA
-
The xDAPT External Validation Study
NCT06736626 ·Status: COMPLETED
-
Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
NCT03214601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)
NCT02650128 ·Status: COMPLETED ·Phase: NA
-
Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)
NCT00231270 ·Status: COMPLETED ·Phase: PHASE3
-
RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
NCT03584464 ·Status: COMPLETED ·Phase: NA